SciELO - Scientific Electronic Library Online

 
vol.129 número1Tratamiento de la insuficiencia cardíaca avanzada mediante trasplante de corazónInstrumento de evaluación funcional de la discapacidad en rehabilitación.: Estudio de confiabilidad y experiencia clínic a con el uso del Functional Independence Measure índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

VEGA R, Inés et al. Hepatitis C virus in a group of hematological and oncohematological patients. Rev. méd. Chile [online]. 2001, vol.129, n.1, pp.18-22. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872001000100003.

Background: Little information is available in Chile about hepatitis C virus (HCV) in hematological and oncohematological patients. Aim: To evaluate the prevalence of hepatitis C virus markers in a group of hematological and oncohematological pediatric patients seen at Valdivia Regional Hospital. Patients and methods: Antibodies against virus C, determined by ELISA and viral RNA, determined using RT-polymerase chain reaction, were measured in 54 blood samples from children with hematological diseases (34 with Acute Lymphoblastic Leukaemia, 4 with Hodgkin Diseases, 4 with Haemolytic Anemia, 5 with Sarcomas, 2 with Non-Hodgkin Lymphoma, 2 with Thrombocytopenic Purpura, 1 with an Ependimoma, one with a Wilms Tumor and 1 with a Von Willebrand Disease). Results: All samples were negative for antibodies against hepatitis C virus. Viral RNA was found in four children, all with a diagnosis of acute lymphoblastic leukemia and who received chemotherapy and multiple transfusions. Conclusions: The prevalence of Viral RNA for hepatitis C virus in oncohematological patients in our study is high and associated with the use of chemotherapy and multiple transfusions (Rev Méd Chile 2001; 129: 18-22)

Palabras clave : Hematologic diseases; Hepatitis C; Hepatitis C antibodies; Polymerase chain reaction.

        · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons